BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 12802470)

  • 21. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.
    Kato H; Takita J; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Kuwano H; Oriuchi N; Endo K
    Anticancer Res; 2003; 23(4):3263-72. PubMed ID: 12926062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT/MRI.
    Nowak B; Di Martino E; Jänicke S; Cremerius U; Adam G; Zimny M; Reinartz P; Büll U
    Nuklearmedizin; 1999; 38(8):312-8. PubMed ID: 10615664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT; Oksala N; Salo JA; Helin H; Karhumäki L; Kemppainen J; Sihvo EI; Räsänen JV
    Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancer.
    Couper GW; McAteer D; Wallis F; Norton M; Welch A; Nicolson M; Park KG
    Br J Surg; 1998 Oct; 85(10):1403-6. PubMed ID: 9782025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standardized uptake value based evaluation of lymphoma by FDG and FLT PET/CT.
    Wang R; Zhu H; Chen Y; Li C; Li F; Shen Z; Tian J; Yu L; Xu B
    Hematol Oncol; 2014 Sep; 32(3):126-32. PubMed ID: 23996464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.
    Buck A; Schirrmeister H; Kühn T; Shen C; Kalker T; Kotzerke J; Dankerl A; Glatting G; Reske S; Mattfeldt T
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1317-23. PubMed ID: 12271413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.
    Sauter AW; Winterstein S; Spira D; Hetzel J; Schulze M; Mueller M; Pfannenberg C; Claussen CD; Klotz E; Hann von Weyhern C; Horger MS
    J Nucl Med; 2012 Apr; 53(4):521-9. PubMed ID: 22414637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes.
    Younes-Mhenni S; Janier MF; Cinotti L; Antoine JC; Tronc F; Cottin V; Ternamian PJ; Trouillas P; Honnorat J
    Brain; 2004 Oct; 127(Pt 10):2331-8. PubMed ID: 15361417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of [18]-FDG PET/CT in the initial staging of head and neck cancers].
    Fakhry N; Barberet M; Lussato D; Mundler O; Giovanni A; Zanaret M
    Rev Laryngol Otol Rhinol (Bord); 2007; 128(1-2):3-9. PubMed ID: 17633658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.
    Swisher SG; Maish M; Erasmus JJ; Correa AM; Ajani JA; Bresalier R; Komaki R; Macapinlac H; Munden RF; Putnam JB; Rice D; Smythe WR; Vaporciyan AA; Walsh GL; Wu TT; Roth JA
    Ann Thorac Surg; 2004 Oct; 78(4):1152-60; discussion 1152-60. PubMed ID: 15464463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.
    Higashi K; Ueda Y; Seki H; Yuasa K; Oguchi M; Noguchi T; Taniguchi M; Tonami H; Okimura T; Yamamoto I
    J Nucl Med; 1998 Jun; 39(6):1016-20. PubMed ID: 9627336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
    Delbeke D; Rose DM; Chapman WC; Pinson CW; Wright JK; Beauchamp RD; Shyr Y; Leach SD
    J Nucl Med; 1999 Nov; 40(11):1784-91. PubMed ID: 10565771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography: another useful test for staging esophageal cancer.
    Lightdale CJ
    J Clin Oncol; 2000 Sep; 18(18):3199-201. PubMed ID: 10986051
    [No Abstract]   [Full Text] [Related]  

  • 34. Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer?
    Vatankulu B; Şanlı Y; Kaytan Sağlam E; Kuyumcu S; Özkan ZG; Yılmaz E; Purisa S; Adalet I
    Mol Imaging Radionucl Ther; 2015 Oct; 24(3):120-7. PubMed ID: 27529887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer.
    Calais J; Dubray B; Nkhali L; Thureau S; Lemarignier C; Modzelewski R; Gardin I; Di Fiore F; Michel P; Vera P
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):858-67. PubMed ID: 25680400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glutathione-S-transferase P1, T1 and M1 genetic polymorphisms in neoadjuvant-treated locally advanced gastric cancer: GSTM1-present genotype is associated with better prognosis in completely resected patients.
    Ott K; Lordick F; Becker K; Ulm K; Siewert J; Höfler H; Keller G
    Int J Colorectal Dis; 2008 Aug; 23(8):773-82. PubMed ID: 18443805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18FDG uptake in oesophageal adenocarcinoma: linking biology and outcome.
    Westerterp M; Sloof GW; Hoekstra OS; Ten Kate FJ; Meijer GA; Reitsma JB; Boellaard R; van Lanschot JJ; Molthoff CF
    J Cancer Res Clin Oncol; 2008 Feb; 134(2):227-36. PubMed ID: 17653575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer.
    Jadvar H; Henderson RW; Conti PS
    Mol Imaging Biol; 2006; 8(3):193-200. PubMed ID: 16565910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [18F-Deoxyglucose PET for the staging of oesophageal cancer: influence of histopathological subtype and tumour grading].
    Menzel Ch; Döbert N; Rieker O; Kneist W; Mose S; Teising A; Junginger T; Böttcher HD; Bartenstein P; Grünwald F
    Nuklearmedizin; 2003 Jun; 42(3):90-3. PubMed ID: 12802470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FDG PET and CT in locally advanced adenocarcinomas of the distal oesophagus. Clinical relevance of a discordant PET finding.
    Stahl A; Stollfuss J; Ott K; Wieder H; Fink U; Schwaiger M; Weber WA
    Nuklearmedizin; 2005; 44(6):249-55; quiz N55-6. PubMed ID: 16400385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.